BioPorto A/S
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioPorto A/S
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.
Frequently asked questions
To buy BioPorto A/S stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioPorto A/S by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioPorto A/S is BIOPOR:xcse. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioPorto A/S has its primary listing on NASDAQ OMX Copenhagen. You can trade BioPorto A/S with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioPorto A/S is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include BioPorto A/S as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures - so you can make more informed decisions when considering shares like BioPorto A/S or others.